Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

55 works

Work: Exploring Cellular Immunotherapy Platforms in Multiple Myeloma

  1. Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

    Jaya Lakshmi Thangaraj, Sung‐Hoon Jung, Manh-Cuong Vo +11

    Article20222 citations
    ABI

  2. FT555: Off-the-Shelf CAR-NK Cell Therapy Co-Targeting GPRC5D and CD38 for the Treatment of Multiple Myeloma

    John Reiser, Szeman Ruby Chan, Ketan Mathavan +16

    Article20222 citations
    ABI

  3. Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma

    Zhuoxiao Cao, Cuiqing Yang, Yifang Wang +9

    Article20222 citations
    ABI

  4. Anti-BCMA-CAR NK Cells Expressing Soluble TRAIL: Promising Therapeutic Approach for Multiple Myeloma in Combination with Bortezomib and γ-Secretase Inhibitors

    Benjamin Motais, Sandra Charvátová, Matouš Hrdinka +2

    Article20222 citations
    ABI

  5. Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer

    Xin Zhang, Zheng Xu, Xiangpeng Dai +2

    Review article20232 citations
    ABI